Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Non-Current Deffered Revenue: 2017-2018

Historic Non-Current Deffered Revenue for Cogent Biosciences (COGT) over the last 1 years, with Dec 2018 value amounting to $748,000.

  • Cogent Biosciences' Non-Current Deffered Revenue fell 91.42% to $748,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $748,000, marking a year-over-year decrease of 91.42%. This contributed to the annual value of $748,000 for FY2018, which is 91.42% down from last year.
  • According to the latest figures from Q4 2018, Cogent Biosciences' Non-Current Deffered Revenue is $748,000, which was down 14.12% from $871,000 recorded in Q3 2018.
  • Over the past 5 years, Cogent Biosciences' Non-Current Deffered Revenue peaked at $8.7 million during Q4 2017, and registered a low of $748,000 during Q4 2018.
  • For the 2-year period, Cogent Biosciences' Non-Current Deffered Revenue averaged around $3.0 million, with its median value being $888,000 (2018).
  • Data for Cogent Biosciences' Non-Current Deffered Revenue shows a maximum YoY tumbled of 91.42% (in 2018) over the last 5 years.
  • Quarterly analysis of 2 years shows Cogent Biosciences' Non-Current Deffered Revenue stood at $8.7 million in 2017, then plummeted by 91.42% to $748,000 in 2018.
  • Its Non-Current Deffered Revenue was $748,000 in Q4 2018, compared to $871,000 in Q3 2018 and $888,000 in Q2 2018.